Bupropion for SSRI-induced sexual dysfunction in women

MOspace/Manakin Repository

Breadcrumbs Navigation

Bupropion for SSRI-induced sexual dysfunction in women

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7857

[+] show full item record


Title: Bupropion for SSRI-induced sexual dysfunction in women
Author: Mancl, Erin; Kraus, Connie
Keywords: sexual drive
sexual cycle
pharmacotherapy
Date: 2010-05
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 13(5): 14.
Abstract: For selective serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction in women, bupropion sustained-release (SR) 150 mg twice daily is similar to placebo in its effect on most measures of sexual function and interest, but is more likely to improve sexual desire, as indicated by an increase in the frequency of sexual activity. Patients taking bupropion SR reported more dry mouth, headache, and irritability, but also less anxiety, stress, fatigue, and mood lability than patients taking placebo. (SOR C, based on extrapolation of data from a single randomized trial.)
URI: http://hdl.handle.net/10355/7857

This item appears in the following Collection(s)

[+] show full item record